Stay updated on Talazoparib in BRCA+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Talazoparib in BRCA+ Breast Cancer Clinical Trial page.

Latest updates to the Talazoparib in BRCA+ Breast Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedLocations section updated with an expanded, country- and city-level list of study sites across the US, Australia, Europe, and other regions; revision: v3.3.3.SummaryDifference1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedRevision: v3.3.2 was added and the previous v3.3.1 revision was removed. There are no visible changes to the study content or page layout beyond the revision tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check44 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and updated the revision label to v3.3.1. The previous PubMed-related wording was removed/replaced with the new wording.SummaryDifference0.0%

- Check51 days agoChange DetectedThe government funding banner was removed from the page; all study details and locations remain unchanged.SummaryDifference0.1%

- Check65 days agoChange DetectedThe screenshots show only minor visual/layout adjustments; no substantive changes to the study record, including eligibility criteria, endpoints, or location listings. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check94 days agoChange DetectedCore page content updated with a government funding status notice and explicit open status of the NIH Clinical Center; version updated from v3.0.2 to v3.2.0.SummaryDifference1%

Stay in the know with updates to Talazoparib in BRCA+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talazoparib in BRCA+ Breast Cancer Clinical Trial page.